Sex differences in immune responses that underlie COVID-19 disease outcomes - Takahashi, Takehiro; Ellingson, Mallory K.; Wong, Patrick; Israelow, Benjamin; Lucas, Carolina; Klein, Jon; Silva, Julio; Mao, Tianyang; Oh, Ji Eun; Tokuyama, Maria; Lu, Peiwen; Venkataraman, Arvind; et al. (Nature (London), 2020)
Keywords: 13; 13/1; 13/21; 13/31; 631/250/255/2514; 631/250/256/2516; 631/326/596/4130; Age; Antibodies; Body mass index; Cell activation; Chemokines; Chemokines - blood; Chemokines - immunology; Cohort Studies; Coronaviridae; Coronaviruses; COVID-19; COVID-19 - blood; COVID-19 - immunology; COVID-19 - virology; Cytokines; Cytokines - blood; Cytokines - immunology; Demographics; Disease Progression; Female; Females; Gender aspects; Gender differences; Growth factors; Hepatitis; Humanities and Social Sciences; Humans; Immune response; Immunity, Innate - immunology; Immunomodulation; Immunomodulators; Interleukin 18; Interleukin 8; Lymphocyte Activation; Lymphocytes; Lymphocytes T; Male; Men; Monocytes; Monocytes - immunology; multidisciplinary; Observations; Patients; Phenotype; Phenotyping; Plasma; Plasma levels; Prognosis; Respiratory diseases; RNA, Viral - analysis; Robustness; SARS-CoV-2 - immunology; SARS-CoV-2 - pathogenicity; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Sex; Sex Characteristics; Sex differences; Sexes; Signs and symptoms; T-Lymphocytes - immunology; Viral diseases; Viral Load; China